Rehabilitation counseling for patients with interstitial lung disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on patients with idiopathic pulmonary fibrosis (IPF), a chronic lung disease that leads to progressive loss of lung function. It aims to observe the effects of rehabilitation counseling provided to patients attending the IPF clinic at the IRCCS Company Bologna University Hospital. The study utilizes a multidisciplinary approach as part of a diagnostic therapeutic care path for pulmonary fibrosis, assessing how rehabilitation can improve physical and emotional well-being in these patients.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* age\>/= 18 years old;
* Obtaining the patient\'s informed consent

Exclusion Criteria:

* Diagnosis of active cancer
* Situations of clinical instability, clinical aggravation such as to consider unsuitable the individual to treatment because he or she is no longer able to go to follow-up visits

Where it's running

• IRCCS Azienda Ospedaliero-Universitaria di Bologna
  Bologna, Bologna, Italy Recruiting

Study contacts

• Principal investigator: Enrica Cavalli, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
• Study coordinator: Enrica Cavalli, MD
• Email: enrica.cavalli@aosp.bo.it
• Phone: 0512142285

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• HOXB7 and related lung and blood biomarkers in pulmonary fibrosis

  This pilot study will test whether levels of HOXB7 and other molecules in lung tissue and blood exosomes can serve as biomarkers in adults with pulmonary fibrosis.

  Recruiting University of Modena and Reggio Emilia · Modena · NCT07373288

• Measuring breathing effort in patients with idiopathic pulmonary fibrosis

  This study is trying to see how hard people with idiopathic pulmonary fibrosis have to work to breathe, to better understand how the disease is progressing.

  Recruiting University of Modena and Reggio Emilia · Modena · NCT05310669

• AccuPulmo CT Portal for Detecting Pulmonary Fibrosis on Chest CT

  This study tests how well the AccuPulmo CT Portal can identify pulmonary fibrosis on existing chest CT scans from adults at Taichung Veterans General Hospital.

  Recruiting Taichung Veterans General Hospital · Taichung · NCT07761377

• Advanced imaging to see how immunosuppression affects lung fibrosis activity

  This trial will test whether immunosuppression changes PET and MRI measurements of active collagen deposition and tissue injury in people with non‑IPF interstitial lung disease who are starting treatment.

  Recruiting Phase 2 Massachusetts General Hospital · Boston, Massachusetts · NCT07572383

• 68Ga-NI-FAPI-04 PET/CT imaging to detect fibroblast activation in cancer, fibrotic, and heart diseases

  This test will see if an injected PET tracer called 68Ga-NI-FAPI-04 can better show fibroblast activation in people with tumors, pulmonary fibrosis, certain autoimmune vascular diseases, hypertrophic cardiomyopathy, or other cardiovascular conditions.

  Recruiting Phase 1/2 Peking Union Medical College Hospital · Beijing, Beijing Municipality · NCT07464132

• Home monitoring for patients with pulmonary fibrosis

  This study tests if using home monitoring and video calls can help people with pulmonary fibrosis manage their condition as well as or better than regular clinic visits.

  Recruiting at 11 sites Erasmus Medical Center · Amsterdam and 10 other locations · NCT06883448

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.